BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15578362)

  • 1. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.
    Jaffe D; Jakubowski A; Sepkowitz K; Sebti R; Kiehn TE; Pamer E; Papanicolaou GA
    Clin Infect Dis; 2004 Dec; 39(11):1625-32. PubMed ID: 15578362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.
    Kersun LS; Propert KJ; Lautenbach E; Bunin N; Demichele A
    Pediatr Blood Cancer; 2005 Aug; 45(2):162-9. PubMed ID: 15593235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.
    Gassas A; Grant R; Richardson S; Dupuis LL; Doyle J; Allen U; Abla O; Sung L
    J Clin Oncol; 2004 Apr; 22(7):1222-7. PubMed ID: 15051769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes.
    Mrazova M; Docze A; Buckova E; Bucko L; Kacmarikova M; Grey E; Korcova J; Koprnova J; Saboova Z; Beno P; Karvaj M; Svetlansky I; Ondrus A; Benca J; Taziarova M; Rudinsky B; Krcmery V
    Scand J Infect Dis; 2005; 37(9):637-41. PubMed ID: 16126562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Graber CJ; de Almeida KN; Atkinson JC; Javaheri D; Fukuda CD; Gill VJ; Barrett AJ; Bennett JE
    Bone Marrow Transplant; 2001 Mar; 27(5):537-42. PubMed ID: 11313689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.
    Seo SK; Xiao K; Huang YT; Jongwutiwes U; Chung D; Maloy M; Giralt S; Barker JN; Jakubowski AA; Papanicolaou GA
    J Infect; 2014 Oct; 69(4):341-351. PubMed ID: 24931578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Mikulska M; Del Bono V; Prinapori R; Boni L; Raiola AM; Gualandi F; Van Lint MT; Dominietto A; Lamparelli T; Cappellano P; Bacigalupo A; Viscoli C
    Transpl Infect Dis; 2010 Dec; 12(6):505-12. PubMed ID: 20636482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients.
    Almyroudis NG; Fuller A; Jakubowski A; Sepkowitz K; Jaffe D; Small TN; Kiehn TE; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2005 Mar; 7(1):11-7. PubMed ID: 15984943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation.
    Bilgrami S; Feingold JM; Dorsky D; Edwards RL; Clive J; Tutschka PJ
    Bone Marrow Transplant; 1998 Mar; 21(6):591-5. PubMed ID: 9543063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viridans streptococcal bacteraemia: a clinical survey.
    Sriskandan S; Soto A; Evans TJ; Cohen J
    QJM; 1995 Jun; 88(6):415-20. PubMed ID: 7648233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.
    Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA
    Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
    Kersting S; Hené RJ; Koomans HA; Verdonck LF
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
    Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
    Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of amoxicillin prophylaxis on the incidence, nature, and duration of bacteremia in children after intubation and dental procedures.
    Lockhart PB; Brennan MT; Kent ML; Norton HJ; Weinrib DA
    Circulation; 2004 Jun; 109(23):2878-84. PubMed ID: 15173031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
    Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
    Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.